Anuhya Penmetsa

Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function.

D. Sriram, D. Dasari, S. Goyal, 2023, European journal of pharmacology.